Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans
Open accessThe DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Abstract
Recent studies suggest that the anabolic effect of ecdysterone, a naturally occurring steroid hormone claimed to enhance physical performance, is mediated by estrogen receptor (ER) binding. In comparison with the prohibited anabolic agents (e.g., metandienone and others), ecdysterone revealed to be even more effective in a recent study performed in rats. However, scientific studies in humans are very rarely accessible. Thus, our project aimed at investigating the effects of ecdysterone-containing products on human sport exercise. A 10-week intervention study of strength training of young men (n = 46) was carried out. Different doses of ecdysterone-containing supplements have been administered during the study to evaluate the performance-enhancing effect. Analysis of blood and urine samples for ecdysterone and potential biomarkers of performance enhancement has been conducted. To ensure the specificity of the effects measured, a comprehensive screening for prohibited performance-enhancing substances was also carried out. Furthermore, the administered supplement has been tested for the absence of anabolic steroid contaminations prior to administration. Significantly higher increases in muscle mass were observed in those participants that were dosed with ecdysterone. The same hypertrophic effects were also detected in vitro in C2C12 myotubes. Even more relevant with respect to sports performance, significantly more pronounced increases in one-repetition bench press performance were observed. No increase in biomarkers for liver or kidney toxicity was noticed. These data underline the effectivity of an ecdysterone supplementation with respect to sports performance. Our results strongly suggest the inclusion of ecdysterone in the list of prohibited substances and methods in sports in class S1.2 "other anabolic agents".
Overview
CoChat Summary
TL;DR
This 10-week intervention study in 46 young men found that ecdysterone supplementation was associated with greater gains in muscle mass and one-repetition bench press performance than comparison conditions. The authors report no increase in liver or kidney toxicity biomarkers and argue ecdysterone should be considered a prohibited anabolic agent in sport.
Key findings
- In a 10-week strength-training intervention with young men (n = 46), participants receiving ecdysterone had significantly higher increases in muscle mass.
- The same hypertrophic effect was reported in vitro in C2C12 myotubes.
- Participants dosed with ecdysterone showed significantly more pronounced increases in one-repetition bench press performance.
- The paper reports no increase in biomarkers for liver or kidney toxicity.
Methods
- Design: 10-week intervention study during strength training; different doses of ecdysterone-containing supplements were administered to evaluate performance-enhancing effects.
- Sample/data: Young men (n = 46); blood and urine samples were analyzed for ecdysterone and potential biomarkers of performance enhancement.
- Main analysis: Compared effects on muscle mass and bench press performance; also performed a comprehensive screening for prohibited performance-enhancing substances and tested the supplement for anabolic steroid contamination before administration.
Limitations
- The paper states that scientific studies in humans are very rarely accessible, indicating limited prior human evidence.
- The text provided does not state specific limitations of the study design, but it is evident from the excerpt that the sample was small (n = 46) and limited to young men.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 1 Not checked · 7 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Significantly higher increases in muscle mass were observed in those participants that were dosed with ecdysterone.”
plainstates a causen = 46- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Even more relevant with respect to sports performance, significantly more pronounced increases in one-repetition bench press performance were observed.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No increase in biomarkers for liver or kidney toxicity was noticed.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The same hypertrophic effects were also detected in vitro in C2C12 myotubes.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In comparison with the prohibited anabolic agents (e.g., metandienone and others), ecdysterone revealed to be even more effective in a recent study performed in rats.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
1 more claim
Create a free account to see all 9 claims and every source verdict.
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to experiments performed by Wilborn et al. (72), Isenman et al. observed that daily doses of 5mg/kg/BW ecdysterone (i.e., several times more concentrated than the doses administered by Wilborn et al.) induced anabolic effects (73).”
From The Inclusion in WADA Prohibited List Is Not Always Supported by Scientific Evidence: A Narrative Review (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In our study, both ecdysteroids mitigated muscle atrophy in the tibialis anterior and soleus, which effect is consistent with their anabolic activity [5,6,8].”
From Prevention of Diet-Induced Obesity by Phytoecdysteroids 20-Hydroxyecdysone and Calonysterone—Unexpected Modulation of Androgen Balance in Normal and Obese Rats (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One of the most intriguing properties of 20E in mammals is its anabolic effect, which is similar to that of anabolic steroids, yet it lacks an androgenic effect [14] and has low toxicity [15,16].”
From Beneficial Effects of Asparagus officinalis Extract Supplementation on Muscle Mass and Strength following Resistance Training and Detraining in Healthy Males (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, a recent study involving young men found that supplementing with 48 mg/day of ecdysterone for 10 weeks increased muscle mass and strength [15].”
From Beneficial Effects of Asparagus officinalis Extract Supplementation on Muscle Mass and Strength following Resistance Training and Detraining in Healthy Males (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“No biomarkers of liver or kidney toxicity were detected in the blood and urine samples.”
From Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
33 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Wisløff, U., Castagna, C., Helgerud, J., Jones, R., & Hoff, J. (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2002.002071 · Cited by 1,125
Phytoecdysteroids: Biological aspects
Dinan, L. (2001) · Phytochemistry · doi:10.1016/s0031-9422(01)00078-4 · Cited by 392 · cited 1×
“2002; Dinan 2001, 2009; Dinan and Lafont 2006; Gorelick-Feldman et al.”
BackgroundRecent developments in the use and abuse of growth promoters
Courtheyn, D., Le Bizec, B., Brambilla, G., De Brabander, H. F., Cobbaert, E., Van de Wiele, M., Vercammen, J., & De Wasch, K. (2002) · Analytica Chimica Acta · doi:10.1016/s0003-2670(02)00753-5 · Cited by 256
Phytoecdysteroids and Anabolic Androgenic Steroids--Structure and Effects on Humans
Bathori, M., Toth, N., Hunyadi, A., Marki, A., & Zador, E. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783330674 · Cited by 201
Effects and applications of arthropod steroid hormones (ecdysteroids) in mammals
Dinan, L., & Lafont, R. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06900 · Cited by 200
Practical uses for ecdysteroids in mammals including humans: and update
Lafont, R., & Dinan, L. (2003) · Journal of Insect Science · doi:10.1093/jis/3.1.7 · Cited by 196 · cited 1×
“Extensive investigations on the possible growth-promoting effects of ecdysterone in various animal species (rats, mice, Japanese quail and cattle) and a few in humans were reported (Bathori et al. 2008; Courtheyn et al. 2002; Dinan 2001, 2009; Dinan and Lafont 2006; Gorelick-Feldman et al. 2008; Haupt et al. 2012; Kum…”
BackgroundPractical uses for ecdysteroids in mammals including humans: And update
Lafont, R., & Dinan, L. (2003) · Journal of Insect Science · doi:10.1673/031.003.0701 · Cited by 196
Phytoecdysteroids increase protein synthesis in skeletal muscle cells.
Gorelick-Feldman, J., MacLean, D., Ilic, N., Poulev, A., Lila, M. A., Cheng, D., & Raskin, I. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf073059z · Cited by 166
Research works printed but not linked: 4
- Haupt O, Tchoukouegno Ngueu S, Diel P, Parr M (2012) Anabolic effect of ecdysterone results in hypertrophy of C2C12 myotubes by an estrogen receptor mediated pathway. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent advances in dope analysis. Sport und Buch Strauß, Cologne
- Joao GA, Evangelista AL, Gomes JH et al (2014) Effect of 16 weeks of periodized resistance training on strength gains of powerlifting athletes. J Exerc Physiol Online 17(3):102–110
- Parr MK, Haupt O, Ngueu ST, Fritzemeier K-H, Muhn P, Diel PR (2013) Estrogen receptor beta mediated anabolic effects—insights from mechanistic studies on the phytoecdysteroid ecdysterone and selective ligands. Endocrine reviews 5:6. https://doi.org/10.1210/endo-meetings.2013.nrsha.3.sat-340 · doi:10.1210/endo-meetings.2013.nrsha.3.sat-340
- Tchoukouegno Ngueu S (2013) Bioactivity of plants secondary metabolites: Estrogenic, cytotoxic and anabolic effects on estrogen target organs of an extract of Erythrina excelsa and Ecdysterone. German Sport University, Cologne
Cited by
Items 101–124 of 124
Ecdiesteroides y su actividad farmacológica sobre el músculo esquelético
Egocheaga, V. O. (2023) · Ars Pharmaceutica (Internet) · doi:10.30827/ars.v64i4.28863
Hermann, R. (2023) · Ernährung & Medizin · doi:10.1055/a-2100-0350
“J Clin Med 2021; 10: 4373 [29] Isenmann E, Ambrosio G, Joseph JF.”
BackgroundInfluentialGuedes, V. C., Machado, M. T. P., & Bachur, T. P. R. (2023) · Revista Intertox de Toxicologia Risco Ambiental e Sociedade · doi:10.22280/revintervol16ed3.553 · Cited by 1
Comorbidity of asthenic syndrome and primary headaches in students of a medical university
Akhmedova, K. N., Мирзаева, Л. М., & Zuev, A. (2024) · Vrach · doi:10.29296/25877305-2024-08-06
Zhou, Y., Li, J. J., Li, L., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5260631
Lu, T., Jia, W., Wang, Y., Ma, Y., Du, F., Gao, H., Song, C., Li, H., Jin, X., Liu, C., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5262501
Strength Gains Across Performance Levels and Sexes: A Meta-Analytical PerspectivePreprint
Held, S., Havers, T., Gavanda, S., Geisler, S., & Isenmann, E. (2025) · Research Square · doi:10.21203/rs.3.rs-6938909/v1
Self-citationDissemond, J., Lesch, A., Valder, S., Schalla, J., Friedrichsen, S., Geisler, S., Belen, S., Zimmer, P., Flenker, U., Isenmann, E., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7319305/v1
Self-citationPhytoecdysteroids from Silene popovii
Yusupova, U. Y., & Usmanov, D. A. (2025) · Springer eBooks · doi:10.1007/978-3-642-36202-6_298-1
Park, J., Lee, D. Y., Mariano, E., Choi, Y., Han, D., Kim, J. S., Park, J. W. P. J. W., Namkung, S., Lee, S. Y., Lee, H. W., et al. (2026) · Food Science of Animal Resources · doi:10.1007/s44463-025-00003-2 · Cited by 1
“In a recent study, phytoestrogen supplementation significantly increased muscle mass in volunteers and is now used in sports to improve performance (Isenmann et al., 2019).”
Chowaniec, P., Miedziaszczyk, M., Kucia, M., Konieczny, M., & Idasiak‐Piechocka, I. (2026) · Cureus · doi:10.7759/cureus.104852 · Cited by 1
“The results obtained are supported by studies conducted in vitro [30].”
Lobina, C., Carai, M. A. M., & Colombo, G. (2026) · Natural Product Communications · doi:10.1177/1934578x261434480
Dhaliwal, R., & Pope, H. G. (2026) · Performance Enhancement & Health · doi:10.1016/j.peh.2026.100424
Everett, J., Minehan, M., Praet, S., & McKune, A. J. (2026) · Nutrition and Health · doi:10.1177/02601060261431124
Lu, T., Jia, W., Wang, Y., Ma, Y., Song, C., Du, F., Gao, H., Jin, X., Li, H., Liu, C., et al. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00880-5
“For instance, studies on 20E supplementation have shown significant improvements in muscle mass, strength, and endurance without notable adverse effects [23].”
Todorova, V., Ivanova, S., Ardasheva, R., & Ivanov, K. (2026) · Molecules · doi:10.3390/molecules31071090
Gayibova, S., Nasyrova, G. I., Рахмонова, Г. Г., Sabirova, M., Abduazimova, D., Nikitina, E., Verushkina, O., & Ivanišová, E. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3354
Ecdysterone: A Component of Dietary Supplements with Ergogenic Potential?
León, S. A., Robayna, B. P., Romero, C. D., & Brito, N. B. (2026) · Nutraceuticals · doi:10.3390/nutraceuticals6020031
“This specific anabolic mechanism is driven by the activation of estrogen receptor beta (ER-β ) [17,19], thereby bypassing the adverse reactions typically associated with anabolic-androgenic steroids (AAS) [19,21,23].”
InfluentialMetandienone abuse induces hepatotoxicity via dysregulated inflammation and metabolic dysfunction
Ye, Y., Li, J., Chen, Z., Xue, X., & Xi, J. (2026) · Journal of International Medical Research · doi:10.1177/03000605261448774
“34 Isenmann et al. 26 reported that a daily dose of 12 mg ecdys-terone (0.15 mg/kg BW in an 80-kg volunteer) was administered in the normal-dose group (Ec1), while the high-dose group (Ec2) received 48 mg daily (0.6 mg/kg BW in an 80-kg volunteer).”
InfluentialDrug Repurposing Opportunities with Phytoecdysteroids: Emerging Trends and Challenges
Usmanov, D. A., Yusupova, U. Y., & Sagdullaev, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-8423-9_9
Metabolic and Hormonal Modulation by Phytoecdysteroids in Mammals
Lafont, R. (2026) · Springer eBooks · doi:10.1007/978-981-95-8423-9_3
Machine Learning and Artificial Intelligence in Phytoecdysteroid Discovery and Analysis
Usmanov, D. A., Yusupova, U. Y., & Rasulev, B. (2026) · Springer eBooks · doi:10.1007/978-981-95-8423-9_8
Lautner, C., Dietzsch, J., Bulla, V., Goshteliani, K., Wiewelhove, T., Geisler, S., Diel, P. R., Parr, M. K., & Isenmann, E. (2026) · Performance Enhancement & Health · doi:10.1016/j.peh.2026.100457
Self-citationSuch, S., & Czernicka, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198565
Metadata
- Authors
- Isenmann, E., Ambrosio, G., Joseph, J. F., Mazzarino, M., de la Torre, X., Zimmer, P., Kazlauskas, R., Goebel, C., Botrè, F., Diel, P., & Parr, M. K.
- Affiliations
- German Sport University Cologne (DE)
- Freie Universität Berlin (DE)
- Federazione Medico Sportiva Italiana (IT)
- National Measurement Institute (AU)
- Corresponding author
- Parr, Maria Kristina
- ORCID
- Venue
- Archives of Toxicology
- Published
- 2019-05-23
- Volume
- 93
- Issue
- 7
- Pages
- 1807-1816
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2946524956
- Cited by
- 127
- References
- 32
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 14 · 2023: 25 · 2022: 14 · 2021: 25 · 2020: 10 · 2019: 4
- FWCI
- 26.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Archives of Toxicology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Funders
- World Anti-Doping Agency (15C18MP)
- Topics
- Social Sciences › Sociology and Political Science › Doping in Sports
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- 20-hydroxyecdysone, ecdysteroids, anabolic agents, performance improvement, resistance training, muscle hypertrophy, estrogen receptor, doping control, C2C12 myotubes, young men
- MeSH terms
- Adult, Animals, Cell Line, Double-Blind Method, Ecdysterone, Humans, Male, Biomarkers, Dietary Supplements, Myoblasts, Anabolic Agents, Mice, Athletic Performance, Resistance Training, Young Adult, Performance-Enhancing Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.